TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.

about

Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.The EMT spectrum and therapeutic opportunities.DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.

P2860

Q38699248-5F4F48F8-EB3D-4108-B4D3-5837033B1ED3 Q39329818-C01E4AD4-E187-4CB9-966E-BAFEC354688A Q53689438-0E0EE382-D641-48AD-9B62-951622304B8D

P2860

TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.

Item

http://www.wikidata.org/entity/Q38718420

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

TET1 promotes cisplatin-resist ...... in promoter in ovarian cancer.

@en

type

Item

label

TET1 promotes cisplatin-resist ...... in promoter in ovarian cancer.

@en

prefLabel

TET1 promotes cisplatin-resist ...... in promoter in ovarian cancer.

@en

P1476

TET1 promotes cisplatin-resist ...... in promoter in ovarian cancer.

@en

P2093

Huilian Hou

http://www.w3.org/2001/XMLSchema#string

Jiaojiao Lu

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Le Zhao

http://www.w3.org/2001/XMLSchema#string

Lijie Wang

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Xi Han

http://www.w3.org/2001/XMLSchema#string

Xu Li

http://www.w3.org/2001/XMLSchema#string

Yuanyi You

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

Multiple Functions of Ten-eleven Translocation 1 during Tumorigenesis

Cancer statistics, 2014

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies

Vimentin DNA methylation predicts survival in breast cancer

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.

Vimentin-Mediated Steroidogenesis Induced by Phthalate Esters: Involvement of DNA Demethylation and Nuclear Factor κB.

P304

405-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CBIN.10734

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28150354

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.

about

P2860

P2860

TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921